The anti-allergic probiotic Kangminyuan has a unique patent, which can reduce serum IgE antibodies and has a preventive and therapeutic effect on allergic asthma. Multiple double-blind placebo-controlled clinical trials as evidence-based medical evidence have also confirmed that it can reduce serum IgE antibodies. Serum IgE immunotherapy can indeed improve the symptoms and recurrence of allergic asthma and allergic rhinitis and conjunctivitis, shorten the drug or hormone treatment cycle, and reduce the medication used by asthma patients (especially children with allergic asthma). The immunotherapy effect of Kangminyuan's anti-allergic probiotics in preventing and treating allergic asthma has been highly recognized by experts at home and abroad, fully demonstrating the advantages of non-drug-specific immunotherapy.
The most ideal treatment strategy for allergic asthma recommended by EAACI:
1. Early diagnosis of allergic asthma in children and coexisting factors with bronchopneumonia should be achieved , achieve an early anti-inflammatory and anti-allergic combined treatment plan;
2. Use the best drug or hormone treatment to control the symptoms of asthma attacks;
3. Take the correct allergy treatment Original diagnostic methods to evaluate the degree of allergic reactions and changes in immune function;
4. Immunomodulatory treatment to change the development of allergic diseases, including avoiding allergen exposure and lowering IgE immunotherapy, through Kangminyuan anti-allergic probiotics bacteria to reduce the allergic antibody IgE in the body, balance the function of immune B cells, reduce the immune response with excessive TH2, induce the correct TH1 type dominant immune response, and adjust the immune function to make the correct immune response to the so-called allergens.
5. Gradually reduce the amount of drug treatment by supplementing the anti-allergic probiotic Kangminyuan and IgE-lowering immunotherapy, using the minimum dose or stopping the anti-allergic or even steroids to control asthma, so that the condition of allergic asthma patients can reach its maximum level. It is best for the disease to remain in a stable state.
Prospects of IgE immunological prevention and treatment of allergic asthma:
There is still a lack of unified immunomodulatory treatment for the prevention and treatment of allergic asthma in my country, whether in children or adults. The combination of Commin's anti-allergic probiotic anti-IgE antibodies and pharmacological asthma control treatments, which should be standard, safe and convenient to take, may provide an unprecedented therapeutic advantage. Kangminyuan's anti-allergic probiotic anti-IgE antibody measures can effectively reduce IgE-mediated allergic reactions and reduce the recurrence of allergic asthma.